Stop wasting hours on dense SEC filings. Get AI-powered summaries of any SEC Filings in seconds. Understand key insights and risks, fast.
Currently we only process Form 8-K, 6-K, 3, 4, 144, Schedule 13D and Schedule 13G. We will support more forms in the future.
Filter by Form Type:
Industry:Biotechnologyβ
2026-04-30BBOT3Form 3 Filing for BridgeBio Oncology Therapeutics, Inc.MEDIUM
This filing details the beneficial ownership of securities for Idan Elmelech, COO & Principal Financial Officer of BridgeBio Oncology Therapeutics, Inc. (BBOT). The filing includes information on directly held Common Stock, specifically 14,838 shares represented by restricted stock units that vest in installments throu...
Small CapBiotechnology
2026-04-30LXEO3Lexeo Therapeutics, Inc. - Form 3 Filing and Power of AttorneyMEDIUM
This filing includes a Form 3, which reports initial beneficial ownership of securities, for Laura Sepp-Lorenzino, a director at Lexeo Therapeutics, Inc. The filing also includes a Limited Power of Attorney, dated April 27, 2026, appointing Youjin Choi, Carole Rosenberg, and James Reilly as attorneys-in-fact. These att...
Small CapBiotechnology